- Vera Therapeutics (NASDAQ:ERA) stated on Monday that it had commenced a public offering to issue and sell $200M of shares, and the underwriters will have a 30-day option to purchase up to an additional 15% of the shares of Class A common stock.
Vera Therapeutics announces $200M public offering
